Nevertheless, our data confirm previously demonstrated associations of L1CAM expression and other high-risk features such as FIGO stage 30, tumour grade 30-32, histological subtypes 30, 31, LVSI 21, 30, 33, and ER and PR status 34. The gene discussed is L1CAM; the disease is neoplasm.